Recently, there has been much debate over whether or not BOTOX can and/or should be used to treat chronic migraines. While one group argues in support of this treatment as a legitimate application of the product, opposition argues that it is perhaps an off label attempt to gain more exposure for the product. It doesn’t matter how strong your argument is for or against the use of BOTOX for the treatment of migraines from an ethical or practical standpoints, because the only opinions that should and do matter are that of the FDA and chronic migraine sufferers; and they happen to support this use of the product.
According to WebMD health news, in October 2010, the FDA approved the use of BOTOX for chronic migraines, which are typically characterized by disabling headaches accompanied by nausea and sensitivity to light and sound and lasting approximately 15 days out of the month. In doing so, a qualified medical specialist administers 31 BOTOX injections into seven specific head and neck sites. Although the results can generally last up to 3 months, they can vary depending on the uniqueness of the individual patient. Furthermore, because the neurological condition known as chronic migraines are often understudied the FDA is now looking into approving the use of BOTOX in an effort to prevent or at the very least greatly diminish the length of the time spent dealing with the painful side effects of chronic migraines. Thus far, studies in both Europe and the United States have shown promising results with respect to diminishing the number of days spent with disabling headaches. When it comes to Athens Botox local patients have a number of options, so make sure to consult with a local medical professional to learn about your procedure!
